Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2019 1
2020 3
2021 10
2022 5
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
Ozonoff A, Jayavelu ND, Liu S, Melamed E, Milliren CE, Qi J, Geng LN, McComsey GA, Cairns CB, Baden LR, Schaenman J, Shaw AC, Samaha H, Seyfert-Margolis V, Krammer F, Rosen LB, Steen H, Syphurs C, Dandekar R, Shannon CP, Sekaly RP, Ehrlich LIR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Sesma AF, Simon V, van Bakel H, Kim-Schulze S, Hafler DA, Levy O, Kraft M, Bime C, Haddad EK, Calfee CS, Erle DJ, Langelier CR, Eckalbar W, Bosinger SE; IMPACC Network; Peters B, Kleinstein SH, Reed EF, Augustine AD, Diray-Arce J, Maecker HT, Altman MC, Montgomery RR, Becker PM, Rouphael N. Ozonoff A, et al. Nat Commun. 2024 Jan 3;15(1):216. doi: 10.1038/s41467-023-44090-5. Nat Commun. 2024. PMID: 38172101 Free PMC article.
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
Ozonoff A, Schaenman J, Jayavelu ND, Milliren CE, Calfee CS, Cairns CB, Kraft M, Baden LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau KC, Davis MM, Hough CL, Messer WB, Higuita NIA, Metcalf JP, Atkinson MA, Brakenridge SC, Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N; IMPACC study group members. Ozonoff A, et al. EBioMedicine. 2022 Sep;83:104208. doi: 10.1016/j.ebiom.2022.104208. Epub 2022 Aug 8. EBioMedicine. 2022. PMID: 35952496 Free PMC article.
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition.
Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman MC, Krammer F, van Bakel H; IMPACC Network; Maecker HT, Rouphael N, Diray-Arce J, Wigdahl B, Kutzler MA, Cairns CB, Haddad EK, Comunale MA. Haslund-Gourley BS, et al. Nat Commun. 2024 Jan 9;15(1):404. doi: 10.1038/s41467-023-44211-0. Nat Commun. 2024. PMID: 38195739 Free PMC article.
Previously infected vaccinees broadly neutralize SARS-CoV-2 variants.
Leier HC, Bates TA, Lyski ZL, McBride SK, Lee DX, Coulter FJ, Goodman JR, Lu Z, Curlin ME, Messer WB, Tafesse FG. Leier HC, et al. Among authors: lyski zl. medRxiv [Preprint]. 2021 Apr 29:2021.04.25.21256049. doi: 10.1101/2021.04.25.21256049. medRxiv. 2021. PMID: 33948601 Free PMC article. Preprint.
Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.
Powers JM, Lyski ZL, Weber WC, Denton M, Streblow MM, Mayo AT, Haese NN, Nix CD, Rodríguez-Santiago R, Alvarado LI, Rivera-Amill V, Messer WB, Streblow DN. Powers JM, et al. Among authors: lyski zl. PLoS Negl Trop Dis. 2023 Mar 13;17(3):e0011154. doi: 10.1371/journal.pntd.0011154. eCollection 2023 Mar. PLoS Negl Trop Dis. 2023. PMID: 36913428 Free PMC article.
Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum.
Bates TA, Leier HC, Lyski ZL, McBride SK, Coulter FJ, Weinstein JB, Goodman JR, Lu Z, Siegel SAR, Sullivan P, Strnad M, Brunton AE, Lee DX, Adey AC, Bimber BN, O'Roak BJ, Curlin ME, Messer WB, Tafesse FG. Bates TA, et al. Among authors: lyski zl. Nat Commun. 2021 Aug 26;12(1):5135. doi: 10.1038/s41467-021-25479-6. Nat Commun. 2021. PMID: 34446720 Free PMC article.
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum.
Bates TA, Leier HC, Lyski ZL, McBride SK, Coulter FJ, Weinstein JB, Goodman JR, Lu Z, Siegel SAR, Sullivan P, Strnad M, Brunton AE, Lee DX, Curlin ME, Messer WB, Tafesse FG. Bates TA, et al. Among authors: lyski zl. medRxiv [Preprint]. 2021 Apr 9:2021.04.04.21254881. doi: 10.1101/2021.04.04.21254881. medRxiv. 2021. Update in: Nat Commun. 2021 Aug 26;12(1):5135. doi: 10.1038/s41467-021-25479-6. PMID: 33851185 Free PMC article. Updated. Preprint.
The time between vaccination and infection impacts immunity against SARS-CoV-2 variants.
Bates TA, Leier HC, McBride SK, Schoen D, Lyski ZL, Lee DX, Messer WB, Curlin ME, Tafesse FG. Bates TA, et al. Among authors: lyski zl. medRxiv [Preprint]. 2023 Jan 4:2023.01.02.23284120. doi: 10.1101/2023.01.02.23284120. medRxiv. 2023. Update in: JCI Insight. 2023 Mar 8;8(5):e165265. doi: 10.1172/jci.insight.165265. PMID: 36656773 Free PMC article. Updated. Preprint.
27 results